Zichron Yaakov, Israel

Sarit Larisch

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 1.3

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Sarit Larisch: Innovator in Cancer Treatment

Introduction

Sarit Larisch is a notable inventor based in Zichron Yaakov, Israel. He has made significant contributions to the field of cancer research through his innovative patents. With a total of two patents, Larisch focuses on developing novel compounds and methods for treating premalignant and malignant cells.

Latest Patents

Larisch's latest patents include groundbreaking work on apoptosis-related protein in the TGF-beta signaling pathway. His first patent involves ARTS mimetic compounds that serve as antagonists for XIAP and Bcl-2. These compounds induce apoptosis and differentiation in premalignant and malignant cells, effectively restoring their normal-like phenotype. The second patent addresses the treatment of Bcl-2 over-expressing disorders using ARTS containing a BH3-like domain. This invention provides an antagonist of a Bcl-2 prosurvival protein, offering new methods and compositions for treating related disorders.

Career Highlights

Sarit Larisch is associated with Carmel-Haifa University Economic Corporation Ltd., where he continues to advance his research and innovations. His work has garnered attention for its potential impact on cancer therapies.

Collaborations

Larisch collaborates with Dalit Barkan, a fellow researcher, to further explore the applications of his inventions in the medical field.

Conclusion

Sarit Larisch's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies. His work continues to pave the way for advancements in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…